论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Luo H, Yang HL, Wei T, Gong YP, Su AP, Ma Y, Zou XH, Lei JY, Zhao WJ, Zhu JQ
Received 10 December 2016
Accepted for publication 27 February 2017
Published 15 May 2017 Volume 2017:13 Pages 635—641
DOI https://doi.org/10.2147/TCRM.S129910
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Professor Deyun Wang
Background and
aim: The optimal approach to detect and treat symptomatic hypocalcemia (SxH)
after thyroidectomy is still uncertain. In our retrospective study, we sought
to set a standardized postoperative management protocol on the basis of
relative change of parathyroid hormone (PTH) and absolute value of
postoperative day 1 (POD1) PTH.
Methods: Patients who underwent thyroidectomy were identified retrospectively in
our prospective database. Blood was collected 1 day before surgery and on
POD1. Extra calcium and calcitriol supplement was prescribed when necessary.
Meanwhile, postoperative signs of SxH were treated and recorded in detail.
Patients were followed up for 1 month after surgery and then 3 months
thereafter.
Results: A total of 744 patients were included in the final analysis. Transient
SxH occurred in 86 (11.6%) patients, and persistent SxH occurred in 4 (0.54%)
patients in more than half year after surgery. Relative decrease of PTH reached
its maximal discriminative effect at 70% (area under the curve [AUC] =0.754),
with a sensitivity of 72.1% and a specificity of 75%. In Group 1 (≤70%),
24 (4.67%) patients were interpreted as having SxH, whereas in Group 2, 62
(27.0%) patients had SxH (>70%), P <0.001. Days of symptom relief
in Group 1–1 (1, 2) were significantly shorter than those in Group 2–2 (1, 10), P =0.023. In Group
2, 112 (80%) patients with POD1 PTH <1 pmol/L were treated with
calcitriol, whereas only 8 (8.89%) patients with POD1 PTH ≥1 pmol/L were
treated with calcitriol (P <0.001).
According to relief of SxH and recovery of parathyroid function, treating with
and without calcitriol showed no difference in patients with POD1 PTH <1 and
≥1 pmol/L.
Conclusion: Relative decrease of PTH >70% is a significant risk factor for SxH in
post-thyroidectomy. The decreasing percent of PTH ≤70% ensures discharge on
POD1, but longer hospitalization was advocated for patients with decreasing
percent of PTH >70%, who needed extra calcitriol supplement when POD1 PTH
<1 pmol/L.
Keywords: parathyroid hormone, PTH, relative change, thyroidectomy, calcitriol,
discharge
